LHC Group, Inc. (NASDAQ:LHCG) – Oppenheimer issued their Q1 2019 EPS estimates for LHC Group in a note issued to investors on Tuesday. Oppenheimer analyst M. Wiederhorn anticipates that the health services provider will post earnings per share of $0.66 for the quarter. Oppenheimer currently has a “Buy” rating and a $85.00 target price on the stock. Oppenheimer also issued estimates for LHC Group’s Q2 2019 earnings at $0.77 EPS, Q3 2019 earnings at $0.77 EPS, Q4 2019 earnings at $0.82 EPS and FY2019 earnings at $3.01 EPS.

Several other analysts also recently issued reports on LHCG. Zacks Investment Research downgraded LHC Group from a “hold” rating to a “sell” rating in a report on Tuesday, January 9th. Robert W. Baird restated a “hold” rating and set a $69.00 price objective on shares of LHC Group in a report on Friday, November 10th. Royal Bank of Canada boosted their price objective on LHC Group from $70.00 to $81.00 and gave the stock an “outperform” rating in a report on Tuesday, November 7th. Jefferies Group boosted their price objective on LHC Group from $68.00 to $83.00 and gave the stock a “buy” rating in a report on Tuesday, November 7th. They noted that the move was a valuation call. Finally, Craig Hallum restated a “buy” rating and set a $80.00 price objective (up previously from $67.00) on shares of LHC Group in a report on Tuesday, November 7th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and nine have given a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $77.10.

LHC Group (NASDAQ LHCG) traded down $2.24 during midday trading on Wednesday, reaching $63.62. The company’s stock had a trading volume of 197,229 shares, compared to its average volume of 281,900. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. The firm has a market cap of $1,180.00, a P/E ratio of 27.42, a PEG ratio of 1.73 and a beta of 0.70. LHC Group has a 12-month low of $44.13 and a 12-month high of $76.14.

LHC Group (NASDAQ:LHCG) last posted its quarterly earnings data on Monday, November 6th. The health services provider reported $0.64 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.60 by $0.04. The firm had revenue of $272.90 million for the quarter, compared to the consensus estimate of $265.35 million. LHC Group had a return on equity of 9.52% and a net margin of 4.09%. The business’s revenue for the quarter was up 18.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.54 EPS.

Institutional investors and hedge funds have recently modified their holdings of the company. Nine Chapters Capital Management LLC acquired a new position in shares of LHC Group in the 3rd quarter valued at about $255,000. BNP Paribas Arbitrage SA increased its holdings in shares of LHC Group by 54.0% in the 3rd quarter. BNP Paribas Arbitrage SA now owns 8,662 shares of the health services provider’s stock valued at $614,000 after purchasing an additional 3,037 shares during the period. Vident Investment Advisory LLC acquired a new position in shares of LHC Group in the 3rd quarter valued at about $2,448,000. Linscomb & Williams Inc. acquired a new position in shares of LHC Group in the 2nd quarter valued at about $2,268,000. Finally, Smith Asset Management Group LP acquired a new position in shares of LHC Group in the 3rd quarter valued at about $1,421,000. Institutional investors own 85.41% of the company’s stock.

WARNING: This article was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another publication, it was stolen and reposted in violation of US & international copyright and trademark laws. The original version of this article can be accessed at https://www.thecerbatgem.com/2018/01/18/oppenheimer-weighs-in-on-lhc-group-inc-s-q1-2019-earnings-lhcg.html.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Earnings History and Estimates for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.